论文部分内容阅读
研究目的是评估以流式细胞的DNA倍体,作为子宫内膜癌患者独立预后因素的意义,同时证实DNA倍体是否能够将患者的不同预后纳入分级和分期的同源亚型。
The aim of the study was to evaluate the significance of flow cytometry DNA ploidy as an independent prognostic factor in patients with endometrial cancer and to verify whether DNA ploidy could account for the different prognosis of patients in staging and staging homology subtypes.